![Martin Marion](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Martin S.
Marion is currently the President, Chief Executive Officer & Director at The Hempshire Group, Inc. in the United States since 2021.
Previously, he was the Chief Executive Officer at Cobalis Corp.
and held the position of President, Chief Executive Officer & Director at The Hempshire Group, Inc. from 2021 to 2022.
| Unternehmen | Position | Beginn |
|---|---|---|
The Hempshire Group, Inc. (United States)
 The Hempshire Group, Inc. (United States) Pharmaceuticals: OtherHealth Technology Manufactures and retails cannabidiol hemp cigarettes | Vorstandsvorsitzender | 01.06.2021 |
| Unternehmen | Position | Ende |
|---|---|---|
| THE HEMPSHIRE GROUP, INC. | Vorstandsvorsitzender | 16.12.2022 |
Cobalis Corp.
 Cobalis Corp. Pharmaceuticals: OtherHealth Technology Develops anti allergy medications | Vorstandsvorsitzender | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 3 |
|---|---|
Cobalis Corp.
Cobalis Corp. Pharmaceuticals: OtherHealth Technology Develops anti allergy medications | Health Technology |
The Hempshire Group, Inc. (United States)
The Hempshire Group, Inc. (United States) Pharmaceuticals: OtherHealth Technology Manufactures and retails cannabidiol hemp cigarettes | Health Technology |
The Hempshire Group, Inc.
 The Hempshire Group, Inc. Chemicals: Major DiversifiedProcess Industries Produces, tests and wholesales CBD Isolate, distillate and white labeling | Process Industries |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
